TheScientist ( Posted on April 30, 2015) Scientists in Korea have injected human embryonic stem cell (hESC)-derived retinal support cells into the eyes of four men with macular degeneration, according to a study published today (April 30) in Stem Ce
Written by Catharine Paddock PhD Published: Thursday 5 June 2014 A new study suggests a mechanism to get bone marrow stem cells to differentiate into brain cells. If the proposed method proves to be viable, it could lead to ways of generating new br
EuroStemCell ( posted on Dec 12, 2014) Parkinson's disease affects millions of people worldwide. Although the symptoms can be treated, there is no known cure. Scientists are investigating how regenerative medicine and stem cell science could be used
TheGuardian (Posted on Oct 15, 2014) Patients with a devastating eye disease who had embryonic stem cell therapy to improve their sight have suffered no major side-effects since they had the treatment, scientists report. The study (pdf) represents t
From Hospital for Special Surgery,New York, October 25, 2018 Researchers from the Marcia Dunn and Jonathan Sobel Department of Neurology at Hospital for Special Surgery (HSS) in New York City have announced the opening of recruitment for a phase 3 i
By Dr. Maria Simbra in CBS Pittsburgh August 11, 2017 Father, husband, and vacuum technology coordinator Rene Fogarty is the first person in the United States to get a new drug called Radicava. Its for ALS - amyotrophic lateral sclerosis - also known
FDA News Release May 5, 2017 The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrigs disease. After learning about the use of edaravone
By Helen McArdle in HeraldScotland.com August, 7, 2017 PATIENTS in Scotland are being sought for the first clinical trial in 20 years into a potential new treatment for motor neurone disease that scientists hope will slow its progression. Researche
From MND Scotland August 7, 2018 MND Scotland has announced the launch of the first Motor Neurone Disease (MND) clinical drug trial in Scotland, in over 20 years. MND Scotland, who is part-funding the study in Glasgow, is committing over 1.5 million
From News-Medical.net May 17, 2018 An international study led by biochemists at the University of Liverpool has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary moto
From CISION PR News, England July 8, 2015 A remarkable research initiative is emerging in the North-West of England through collaboration between the Association for the Independence of Disabled People (AID) and medical researchers at Lancaster Univ
By Phillip A, Lo et al. in The Lancet. Neurology October 18, 2018 Abstract: No available treatments slow or halt progression of multiple system atrophy, which is a rare, progressive, fatal neurological disorder. In a mouse model of multiple system a
By Santiago Perez et al. in Movement Disorders Clinical Practice February 2, 2015 Abstract: MSA is a progressive neurodegenerative disorder characterized by autonomic failure and a variable combination of poor levodopa‐responsive parkinsonism and ce
By Tetsuo Ashizawa et al. in Nature Reviews Neurology 2018 Abstract: The spinocerebellar ataxias (SCAs) comprise more than 40 autosomal dominant neurodegenerative disorders that present principally with progressive ataxia. Within the past few years,
By Marilyn Haddrill in allaboutvision.com August 20, 2018 Age-related macular degeneration also called macular degeneration, AMD or ARMD is deterioration of the macula, which is the small central area of the retina of the eye that controls visual ac
